Compounding Pharmacies Fight Back: Fifth Circuit Appeal Filed Over Tirzepatide Injunction Denial
In a significant development within the pharmaceutical compounding industry, the Outsourcing Facilities Association (OFA) has filed an interlocutory appeal to the Fifth Circuit Court of Appeals. This action challenges a recent decision by a federal judge to deny...
Texas Introduces New Bill Targeting Med Spas: House Bill 3749
The Texas legislature is taking a closer look at the med spa industry with the introduction of House Bill 3749, proposed by Representative Angelia Orr on March 4, 2025. This bill is a direct response to growing concerns over patient safety in medical spas,...
Court Ruling Backs FDA, Blocks Compounded Versions of Eli Lilly’s Weight-Loss Drug
In a recent legal development, a U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to continue producing copies of Eli Lilly’s weight-loss medication, Zepbound. This decision stems from an October lawsuit filed by a...
Treasury Department Suspends Enforcement of Corporate Transparency Act for U.S. Citizens and Domestic Companies
On March 2, 2025, the U.S. Treasury Department announced a major shift in its enforcement of the Corporate Transparency Act (CTA), declaring that it will no longer impose penalties or fines on U.S. citizens and domestic reporting companies under the beneficial...